Related news from |
Sat, 04 May 2024 13:16:47 +0000 |
Shareholders Will Probably Hold Off On Increasing Stryker Corporation's (NYSE:SYK) CEO Compensation For The Time Being
Key Insights Stryker will host its Annual General Meeting on 9th of May Total pay for CEO Kevin Lobo includes US$1.39m...
|
Fri, 03 May 2024 12:19:24 +0000 |
Stryker Corporation Just Beat EPS By 6.2%: Here's What Analysts Think Will Happen Next
Stryker Corporation ( NYSE:SYK ) defied analyst predictions to release its quarterly results, which were ahead of...
|
Thu, 02 May 2024 10:21:21 +0000 |
Stryker First Quarter 2024 Earnings: Beats Expectations
Stryker ( NYSE:SYK ) First Quarter 2024 Results Key Financial Results Revenue: US$5.24b (up 9.7% from 1Q 2023). Net...
|
Thu, 02 May 2024 05:02:40 +0000 |
Decoding Stryker Corp (SYK): A Strategic SWOT Insight
Insightful Analysis of Stryker Corp's Financial Health and Market Position
|
Wed, 01 May 2024 20:12:06 +0000 |
Stryker Skids On Light Knee Replacements; Analyst Blames Mis-Modeling
Stryker stock fell Wednesday despite reporting solid 10% organic sales growth due to lighter-than-expected revenue from knee replacements.
|
Wed, 01 May 2024 15:32:25 +0000 |
Stryker Corporation (NYSE:SYK) Q1 2024 Earnings Call Transcript
Stryker Corporation (NYSE:SYK) Q1 2024 Earnings Call Transcript April 30, 2024 Stryker Corporation beats earnings expectations. Reported EPS is $2.5, expectations were $2.35. Stryker Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the First Quarter 2024 Stryker […]
|
Wed, 01 May 2024 13:13:00 +0000 |
Stryker's (SYK) Q1 Earnings Beat Estimates, Guidance Raised
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimates.
|
Wed, 01 May 2024 11:25:34 +0000 |
Q1 2024 Stryker Corp Earnings Call
Q1 2024 Stryker Corp Earnings Call
|
Wed, 01 May 2024 07:27:58 +0000 |
Stryker Corp (SYK) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Optimistic ...
Discover how Stryker Corp achieved significant sales growth and raised its full-year forecasts amidst dynamic market conditions.
|
Tue, 30 Apr 2024 22:11:12 +0000 |
REFILE-Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share to be between $11.85 and $12.05, raised from the previous range of between $11.70 and $12. Stryker now expects organic net sales growth for 2024 to be in the range of 8.5% to 9.5%, compared with its earlier projected range of 7.5% to 9%.
|
Tue, 30 Apr 2024 22:00:08 +0000 |
Here's What Key Metrics Tell Us About Stryker (SYK) Q1 Earnings
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
|
Tue, 30 Apr 2024 21:32:10 +0000 |
Stryker Corp (SYK) Q1 2024 Earnings: Adjusted EPS Exceeds Analyst Expectations
Strong Organic Sales Growth and Improved Operating Margins Highlight the Quarter
|
Tue, 30 Apr 2024 21:25:05 +0000 |
Stryker (SYK) Beats Q1 Earnings and Revenue Estimates
Stryker (SYK) delivered earnings and revenue surprises of 6.38% and 3.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
|
Tue, 30 Apr 2024 20:05:00 +0000 |
Stryker reports first quarter 2024 operating results
Portage, Michigan, April 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2024: First Quarter Results Reported net sales increased 9.7% to $5.2 billionOrganic net sales increased 10.0%Reported operating income margin of 18.5%Adjusted operating income margin(1) increased 80 bps to 21.9%Reported EPS increased 33.1% to $2.05Adjusted EPS(1) increased 16.8% to $2.50 First Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant C
|
Mon, 29 Apr 2024 12:20:00 +0000 |
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Here is a sneak peek into how the five medical device stocks, SYK, GEHC, ECL, NARI and MMSI, might fare in their quarterly results slated to be released tomorrow.
|
Thu, 25 Apr 2024 14:02:01 +0000 |
Analysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for
Agios Pharmaceuticals (AGIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
|
Thu, 25 Apr 2024 13:15:26 +0000 |
Seeking Clues to Stryker (SYK) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Evaluate the expected performance of Stryker (SYK) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
|
Wed, 24 Apr 2024 16:44:00 +0000 |
SYK vs ZBH: Which Stock Looks More Promising Ahead of Q1 Earnings?
SYK and ZBH are expected to have witnessed strong procedural volume growth across the global market in the first quarter.
|
Wed, 24 Apr 2024 12:23:58 +0000 |
What Makes Stryker Corporation (SYK) an Investment Choice?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
|
Wed, 24 Apr 2024 11:00:10 +0000 |
Does Stryker (NYSE:SYK) Deserve A Spot On Your Watchlist?
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
|